UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023126
Receipt number R000026657
Scientific Title Quality of Systematic Reviews Underlying Clinical Practice Guidelines
Date of disclosure of the study information 2016/08/01
Last modified on 2016/07/12 00:21:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Quality of Systematic Reviews Underlying Clinical Practice Guidelines

Acronym

Quality of Systematic Reviews underlying Clinical Practice Guidelines for Opioid Dependence.

Scientific Title

Quality of Systematic Reviews Underlying Clinical Practice Guidelines

Scientific Title:Acronym

Quality of Systematic Reviews underlying Clinical Practice Guidelines for Opioid Dependence.

Region

North America


Condition

Condition

Methodological Quality and completeness of reporting as represented by the AMSTAR tool and PRISMA checklist

Classification by specialty

Medicine in general Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to assess the methodological quality and completeness of reporting in Systematic Reviews underlying current Clinical Practice Guidelines for Opioid Dependence across professional organizations both domestic and international.

Basic objectives2

Others

Basic objectives -Others

To assess the methodological quality and completeness of reporting in Systematic Reviews underlying Clinical Practice Guidelines for Opioid Dependence.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Global Methodological Quality and Completeness of Reporting of Clinical Practice Guidelines as represented by underlying systematic reviews graded with the AMSTAR tool and PRISMA checklist, respectively

Key secondary outcomes

Proportion of recommendations in CPGs with underlying evidence based on Systematic Reviews vs proportion of recommendations not based on systematic reviews.

Quality of evidence underlying key specific recommendations as represented by methodological quality and completeness of reporting of systematic reviews used for each key recommendation.


Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Clinical Practice Guidelines:
1. Clinical Practice Guidelines must be recognized by a national governmental or provider/professional organization.
2. Clinical Practice Guidelines must be in English.
3. Clinical Practice Guidelines must contain recommendations relevant to best practices in the diagnosis, treatment, and/or management of opioid dependence.

Systematic Reviews:
1. Systematic Reviews must be in English.
2. Systematic Reviews must be peer-reviewed and published, or currently in press.
3. The Systematic Review must have performed a systematic search and synthesis of available evidence.

Key exclusion criteria

Clinical Practice Guidelines:
1. Clinical Practice Guidelines without reference lists and those without readily accessible reference lists such as those only accessible by email correspondence will be excluded.
2. Addendums published relevant to one or more recommendations for a CPG will be excluded.
2. CPGs not recognized by a professional organization or governmental body will be excluded.

Systematic Reviews:
1. Systematic reviews of animal studies will be excluded.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Matt Vassar

Organization

Oklahoma State University Center for Health Sciences

Division name

College of Osteopathic Medicine

Zip code


Address

1111 W. 17th St.

TEL

918-582-1972

Email

matt.vassar@okstate.edu


Public contact

Name of contact person

1st name
Middle name
Last name Matt Vassar

Organization

Oklahoma State University Center for Health Sciences

Division name

College of Osteopathic Medicine

Zip code


Address

1111 W. 17th St.

TEL

918-582-1972

Homepage URL

http://www.healthsciences.okstate.edu

Email

matt.vassar@okstate.edu


Sponsor or person

Institute

Oklahoma State University Center for Health Sciences

Institute

Department

Personal name



Funding Source

Organization

N/A

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 07 Month 01 Day

Date of IRB


Anticipated trial start date

2016 Year 07 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

No other related information


Management information

Registered date

2016 Year 07 Month 12 Day

Last modified on

2016 Year 07 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026657


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name